These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37718272)

  • 21. Is another relationship possible? Connoisseurship and the doctor-patient relationship for men who consume performance and image-enhancing drugs.
    Fraser S; Fomiatti R; Moore D; Seear K; Aitken C
    Soc Sci Med; 2020 Feb; 246():112720. PubMed ID: 31972378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone vs. steroids: Comparing the disciplined bodywork projects of performance and image enhancing drug users in Australia.
    James E; Wynn LL
    Int J Drug Policy; 2022 Sep; 107():103776. PubMed ID: 35797841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids.
    Smit DL; de Hon O; Venhuis BJ; den Heijer M; de Ronde W
    Scand J Med Sci Sports; 2020 Mar; 30(3):531-539. PubMed ID: 31663164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body Image and Eating Disorders are Common among Professional and Amateur Athletes Using Performance and Image Enhancing Drugs: A Cross-Sectional Study.
    Piacentino D; Kotzalidis GD; Longo L; Pavan A; Stivali L; Stivali G; Ferracuti S; Brugnoli R; Frati P; Fineschi V; Girardi P; Sani G
    J Psychoactive Drugs; 2017; 49(5):373-384. PubMed ID: 28777732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology.
    Shimko KM; Piatkowski T; Thomas KV; Speers N; Brooker L; Tscharke BJ; O'Brien JW
    J Hazard Mater; 2021 Oct; 419():126340. PubMed ID: 34171672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do performance and image enhancing drug users in regional Queensland experience difficulty accessing health services?
    Dunn M; Henshaw R; McKay FH
    Drug Alcohol Rev; 2016 Jul; 35(4):377-82. PubMed ID: 26644363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintaining the healthy body: Blood management and hepatitis C prevention among men who inject performance and image-enhancing drugs.
    Fomiatti R; Lenton E; Latham JR; Fraser S; Moore D; Seear K; Aitken C
    Int J Drug Policy; 2020 Jan; 75():102592. PubMed ID: 31855731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do you get what you see? The illicit doping market in Denmark-An analysis of performance and image enhancing drugs seized by the police over a 1-year period.
    Heinsvig PJ; Christiansen AV; Ayoubi D; Heisel LS; Lindholst C
    Drug Test Anal; 2023 Jun; 15(6):668-677. PubMed ID: 36932906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diffusion of performance and image-enhancing drugs (PIEDs) on the internet: the abuse of the cognitive enhancer piracetam.
    Corazza O; Bersani FS; Brunoro R; Valeriani G; Martinotti G; Schifano F
    Subst Use Misuse; 2014 Dec; 49(14):1849-56. PubMed ID: 24827869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
    Rowe R; Berger I; Yaseen B; Copeland J
    Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use.
    Hanley Santos G; Coomber R
    Int J Drug Policy; 2017 Feb; 40():35-43. PubMed ID: 27955960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroid users and the unique challenge they pose to needle and syringe program workers.
    Dunn M; McKay FH; Iversen J
    Drug Alcohol Rev; 2014 Jan; 33(1):71-7. PubMed ID: 24400704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Masculinities, practices and meanings: A critical analysis of recent literature on the use of performance- and image-enhancing drugs among men.
    Moore D; Hart A; Fraser S; Seear K
    Health (London); 2020 Nov; 24(6):719-736. PubMed ID: 30922123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Body Dysmorphic-Induced Anabolic-Androgenic Steroid Use With Mental Health Outcomes: A Systematic Review.
    Gawash A; Zia H; Al-Shehab U; Lo DF
    Prim Care Companion CNS Disord; 2023 Oct; 25(5):. PubMed ID: 37923553
    [No Abstract]   [Full Text] [Related]  

  • 37. What factors contributed to the misconduct of health practitioners? An analysis of Australian cases involving the diversion and supply of pharmaceutical drugs for non-medical use between 2010 and 2016.
    Hulme S; Hughes CE; Nielsen S
    Drug Alcohol Rev; 2019 May; 38(4):366-376. PubMed ID: 30887600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Blood letting"-Self-phlebotomy in injecting anabolic-androgenic steroids within performance and image enhancing drug (PIED) culture.
    Brennan R; Wells J; Van Hout MC
    Int J Drug Policy; 2018 May; 55():47-50. PubMed ID: 29518637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Liver King Lie: Misrepresentation, justification, and public health implications.
    Gibbs N; Piatkowski T
    Int J Drug Policy; 2023 Apr; 114():103979. PubMed ID: 36841216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Legislating thresholds for drug trafficking: a policy development case study from New South Wales, Australia.
    Hughes CE; Ritter A; Cowdery N
    Int J Drug Policy; 2014 Sep; 25(5):992-1000. PubMed ID: 24735952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.